Login / Signup

Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock.

Jonas SundermeyerCaroline KellnerBenedikt N BeerLisa BeschAngela DettlingLetizia Fausta BertoldiStefan BlankenbergJeroen DauwZouhir DindaneDennis EcknerIngo EitelTobias GrafPatrick HornJoanna Jozwiak-NozdrzykowskaPaulus KirchhofStefan KlugeAxel LinkeUlf LandmesserPeter LuedikeEnzo LüsebrinkNicolas MajunkeNorman MangnerOctavian ManiucSven Möbius WinklerPeter NordbeckMartin OrbanFederico PappalardoMatthias PauschingerMichal PazdernikAlastair ProudfootMatthew KelhamTienush RassafClemens SchererPaul Christian SchulzeRobert H G SchwingerCarsten SkurkMarek SramkoGuido TavazziHolger ThieleLuca VillanovaNuccia MoriciRalf WestenfeldEphraim B WinzerDirk WestermannBenedikt Schrage
Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
This retrospective study may indicate a lower mortality risk with MCS use only in patients with severely reduced LVEF. This may propose the inclusion of LVEF as an adjunctive parameter for MCS decision-making in non-ischaemic CS, aiming to optimise the benefit-risk ratio. Impact of left ventricular ejection fraction on mortality and use of mechanical circulatory support in non-ischaemic cardiogenic shock. Hazard ratio for 30-day mortality across the LVEF continuum, adjusted for age, sex, SCAI shock stage, worst value of lactate and pH within 6 h, prior resuscitation and mechanical ventilation during the index shock event. LVEF: Left ventricular ejection fraction; MCS: Mechanical circulatory support; HR: Hazard ratio; CI: Confidence interval.
Keyphrases